GlassScriptPhysician profile
Christopher B Kruse
NPI 1083636898
$1,473.87
in general payments reported to CMS, 2019-2025
21 companies · $233 in 2025
The $233 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $307 · 2020: $121 · 2021: $243 · 2022: $150 · 2023: $189 · 2024: $230 · 2025: $233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $652.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $652.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $604.22 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $111.94 | 2019-2024 | |
| Ucb, INC. | $98.41 | 2019-2022 | |
| Leo Pharma INC. | $97.88 | 2020-2022 | |
| Sun Pharmaceutical Industries INC. | $82.71 | 2019-2025 | |
| Galderma Laboratories, L.P. | $72.80 | 2019 | |
| Mayne Pharma Commercial LLC | $49.74 | 2019-2024 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $49.63 | 2021-2025 | Cabtreo, Arazlo |
| Lilly USA, LLC | $47.26 | 2022-2025 | Ebglyss, Taltz |
| Allergan, INC. | $42.97 | 2020-2022 | |
| Dusa Pharmaceuticals, INC. | $37.65 | 2019 | |
| Janssen Biotech, INC. | $33.98 | 2021-2025 | Tremfya |
| Aclaris Therapeutics, INC. | $27.04 | 2019 | |
| Incyte Corporation | $16.28 | 2024 | Opzelura |
| Amgen INC. | $15.81 | 2023 | Otezla, Enbrel |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $15.45 | 2023 | |
| Epi Health, LLC | $14.86 | 2019 | |
| Genentech USA, INC. | $14.66 | 2019 | |
| Almirall LLC | $14.28 | 2019 | |
| Arcutis Biotherapeutics, INC. | $14.14 | 2023 | |
| Prugen, INC. Pharmaceuticals | $12.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Kruse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.